---

primary antibody (subgroup of antibody) → ReceivesAction → incubated	0.84
secondary antibody (subgroup of antibody) → IsA → alexa fluor	0.84
antibody (aspect of plasma) → ReceivesAction → purchased	0.84
antibody → ReceivesAction → purchased	0.82
monoclonal antibody (subgroup of antibody) → ReceivesAction → produced	0.80
antibody → HasProperty → specific	0.78
antibody → ReceivesAction → obtained	0.77
antibody → CapableOf → bind to antigen	0.77
antibody → IsA → protein	0.76
monoclonal antibody (subgroup of antibody) → ReceivesAction → obtained	0.75
antibody → ReceivesAction → purified	0.73
polyclonal antibody (subgroup of antibody) → ReceivesAction → purified	0.72
monoclonal antibody (subgroup of antibody) → ReceivesAction → purchased	0.72
immunoglobulin → IsA → antibody	0.71
primary antibody (subgroup of antibody) → ReceivesAction → diluted in pbs	0.71
antibody → ReceivesAction → produced by immune system	0.71
effect (aspect of antibody) → ReceivesAction → assessed	0.70
secondary antibody (subgroup of antibody) → IsA → conjugated to horseradish peroxidase	0.70
antibody → HasProperty → anti	0.69
antibody → ReceivesAction → produced by single clone of cells	0.69
neutralizing antibody (subgroup of antibody) → HasProperty → effective	0.68
polyclonal antibody (subgroup of antibody) → ReceivesAction → produced	0.68
specific antibody (subgroup of antibody) → CapableOf → bind to specific antigen	0.68
thyroid antibody (subgroup of antibody) → HasProperty → high	0.68
specificity (aspect of antibody) → ReceivesAction → tested	0.68
specificity (aspect of antibody) → ReceivesAction → dependent on chemical composition	0.67
specificity (aspect of antibody) → ReceivesAction → dependent on physical forces	0.67
specificity (aspect of antibody) → ReceivesAction → dependent on molecular structure	0.67
antibody → CapableOf → fight infection	0.67
antibody → ReceivesAction → produced	0.66
antibody → CapableOf → recognize antigen	0.66
antibody → UsedFor → western blotting	0.65
antibody → CapableOf → circulate in the blood	0.65
antibody → ReceivesAction → produced by b cells	0.65
neutralizing antibody (subgroup of antibody) → ReceivesAction → isolated	0.65
effect (aspect of antibody) → HasProperty → small	0.65
antibody → ReceivesAction → used in immunohistochemistry	0.65
monoclonal antibody (subgroup of antibody) → ReceivesAction → given by infusion	0.65
antibody → ReceivesAction → produced by the body	0.65
antibody → HasProperty → reactive	0.65
antibody → IsA → molecule	0.64
antibody → HasProperty → active	0.64
antibody → HasProperty → unique	0.64
specificity (aspect of antibody) → ReceivesAction → determined	0.64
monoclonal antibody (subgroup of antibody) → CapableOf → show similar reactivity	0.63
antibody → CapableOf → destroy virus	0.63
antibody → CapableOf → recognize epitope	0.63
antibody → CapableOf → bind to the virus	0.63
antibody → ReceivesAction → produced in response	0.63
antibody → ReceivesAction → made in the laboratory	0.63
antibody → HasProperty → important	0.63
antibody → CapableOf → bind to protein	0.63
specificity (aspect of antibody) → ReceivesAction → confirmed	0.63
secondary antibody (subgroup of antibody) → ReceivesAction → added	0.63
antibody → ReceivesAction → incubated	0.62
antibody → ReceivesAction → formed	0.62
antibody → ReceivesAction → diluted in pbs	0.62
antibody → ReceivesAction → listed in table	0.61
antibody → HasProperty → polyclonal	0.61
antibody → ReceivesAction → validated for use	0.61
affinity (aspect of antibody) → HasProperty → lower	0.61
antibody → CapableOf → neutralize virus	0.61
antibody → ReceivesAction → used at a dilution of 1:20,000	0.61
monoclonal antibody (subgroup of antibody) → HasProperty → specific	0.61
antibody → CapableOf → fight bacteria	0.61
primary antibody (subgroup of antibody) → ReceivesAction → incubated at 4°c	0.61
antibody → UsedFor → chip	0.60
antibody → HasProperty → identical	0.60
antibody → HasProperty → human	0.60
antibody → HasProperty → positive	0.60
antibody → CapableOf → protect the body	0.60
antibody → ReceivesAction → humanized	0.60
antibody → UsedFor → immunofluorescence	0.59
antibody → ReceivesAction → used in experiment	0.59
antibody → HasProperty → monoclonal	0.59
antibody → ReceivesAction → bound to antigen	0.59
antibody → ReceivesAction → purified by affinity chromatography	0.59
antibody → ReceivesAction → used to identify virus	0.59
antibody → ReceivesAction → biotinylated	0.59
antibody → CapableOf → bind to epitope	0.58
antibody → ReceivesAction → used to identify bacteria	0.58
antibody → CapableOf → attack bacteria	0.58
antibody → ReceivesAction → produced in rabbit	0.58
antibody → ReceivesAction → incubated at 4°c	0.58
primary antibody (subgroup of antibody) → ReceivesAction → diluted in tbst	0.58
antibody → CapableOf → neutralize hiv-1	0.58
antibody → CapableOf → protect the baby	0.58
antibody → ReceivesAction → listed in additional file	0.58
effect (aspect of antibody) → HasProperty → specific	0.58
antibody → ReceivesAction → approved for use	0.57
antibody → HasProperty → cross	0.57
antibody → UsedFor → flow cytometry	0.57
antibody → CapableOf → attack virus	0.57
antibody → ReceivesAction → tested for specificity	0.57
specificity (aspect of antibody) → ReceivesAction → confirmed by western blot	0.57
antibody → ReceivesAction → derived	0.57
effect (aspect of antibody) → HasProperty → transient	0.56
antibody → HasProperty → pathogenic	0.56
antibody → ReceivesAction → used in combination	0.56
antibody → CapableOf → fight virus	0.56
antibody → ReceivesAction → produced by plasma cells	0.56
antibody → ReceivesAction → synthesized	0.56
antibody → HasProperty → effective	0.56
antibody → IsA → large proteins	0.56
secondary antibody (subgroup of antibody) → IsA → conjugated to hrp	0.56
secondary antibody (subgroup of antibody) → IsA → conjugated to fitc	0.56
monoclonal antibody (subgroup of antibody) → HasProperty → useful	0.56
antibody → CapableOf → use for western blot analysis	0.56
antibody → AtLocation → people	0.55
antibody → ReceivesAction → diluted in tbs-tween	0.54
antibody → CapableOf → target respective receptors	0.54
antibody → ReceivesAction → listed in supplemental table	0.54
antibody → HasProperty → protective	0.54
monoclonal antibody (subgroup of antibody) → IsA → antibody	0.54
effect (aspect of antibody) → HasProperty → mild	0.54
antibody → ReceivesAction → prepared	0.54
antibody → ReceivesAction → conjugated	0.54
antibody → HasPrerequisite → dilution	0.54
polyclonal antibody (subgroup of antibody) → CapableOf → prevent against infection	0.54
primary antibody (subgroup of antibody) → ReceivesAction → diluted in blocking solution	0.54
monoclonal antibody (subgroup of antibody) → CapableOf → recognize epitope	0.53
antibody → IsA → y-shaped molecules	0.53
antibody → ReceivesAction → titrated	0.53
antibody → CapableOf → cross react	0.53
antibody → CapableOf → destroy invader	0.53
antibody → HasProperty → higher	0.53
antibody → ReceivesAction → characterized	0.53
antibody → CapableOf → prevent infection	0.53
antibody → ReceivesAction → directed against virus	0.53
antibody → ReceivesAction → bound	0.53
antibody (aspect of plasma) → HasProperty → significant	0.52
antibody → CapableOf → recognize conformational epitope	0.52
antibody → HasProperty → a fab	0.52
antibody → CreatedBy → white blood cells	0.52
antibody → ReceivesAction → linked to enzyme	0.52
antibody → AtLocation → the blood	0.51
polyclonal antibody (subgroup of antibody) → ReceivesAction → raised in rabbit	0.51
antibody → Causes → inflammation	0.51
antibody → HasProperty → ineffective	0.51
effect (aspect of antibody) → ReceivesAction → discussed	0.51
antibody → UsedFor → immunoprecipitation	0.51
antibody → ReceivesAction → concentrated before use	0.51
antibody → HasProperty → stable	0.51
effect (aspect of antibody) → HasProperty → more pronounced	0.50
effect (aspect of antibody) → ReceivesAction → determined	0.50
antibody → ReceivesAction → detected in the blood	0.50
antibody → ReceivesAction → activated	0.50
antibody → ReceivesAction → diluted in 1% bsa	0.50
antibody → ReceivesAction → shown in figure	0.50
saliva → HasA → antibody	0.50
antibody → CapableOf → form complex	0.50
antibody → ReceivesAction → developed	0.50
antibody → ReceivesAction → labeled with horseradish peroxidase	0.50
antibody → CapableOf → fight cancer	0.50
antibody → CapableOf → attack red blood cells	0.50
antibody → CapableOf → destroy bacteria	0.50
antibody → ReceivesAction → produced in mouse	0.50
antibody → ReceivesAction → directed against cd20	0.49
antibody → HasProperty → free	0.49
antibody → IsA → specialized proteins	0.49
antibody → UsedFor → immunocytochemistry	0.49
antibody → Causes → hyperthyroidism	0.49
antibody → ReceivesAction → produced in animal	0.49
antibody → ReceivesAction → used in research	0.49
specificity (aspect of antibody) → HasProperty → high	0.49
specificity (aspect of antibody) → ReceivesAction → limited to single group of proteins	0.49
antibody → ReceivesAction → bound to an immunosorbent substrate	0.49
antibody → ReceivesAction → produced by immunizing animals	0.49
primary antibody (subgroup of antibody) → ReceivesAction → added	0.49
polyclonal antibody (subgroup of antibody) → CapableOf → recognize multiple epitopes	0.48
primary antibody (subgroup of antibody) → IsA → diluted 1/100	0.48
antibody → HasProperty → significant	0.48
antibody → HasA → similar structure	0.48
antibody → ReceivesAction → used at 1 μg/ml	0.48
antibody → HasProperty → successful	0.48
antibody → CapableOf → react	0.48
effect (aspect of antibody) → HasProperty → unknown	0.48
antibody → CapableOf → destroy germ	0.48
antibody → CapableOf → provide protection	0.48
antibody → ReceivesAction → raised in rabbit	0.48
antibody → ReceivesAction → detected in patient	0.48
antibody → CapableOf → neutralize bacteria	0.48
antibody → CapableOf → target virus	0.47
antibody → CapableOf → exhibit same species	0.47
antibody → ReceivesAction → raised in goat	0.47
antibody → ReceivesAction → detected	0.47
antibody → HasProperty → unprimed	0.47
antibody → CapableOf → remain in the body	0.47
antibody → CapableOf → target protein	0.47
antibody → CapableOf → bind to the target	0.47
antibody → CapableOf → bind to cell	0.46
antibody → ReceivesAction → developed in house	0.46
antibody → HasA → higher affinity	0.46
antibody → AtLocation → other bodily fluids	0.46
antibody → CapableOf → stimulate the thyroid gland	0.46
antibody → CapableOf → target pd-1	0.46
antibody → CapableOf → neutralize toxin	0.46
antibody → HasProperty → rare	0.46
antibody → ReceivesAction → directed against antigen	0.46
antibody → CapableOf → bind to the pathogen	0.46
antibody → CapableOf → give positive signal	0.46
antibody → CapableOf → concentrate to 1.0 mg/ml	0.45
antibody → CapableOf → show specificity	0.45
antibody → ReceivesAction → diluted in blocking buffer	0.45
antibody → ReceivesAction → used at concentration	0.45
effect (aspect of antibody) → HasProperty → rash	0.45
secondary antibody (subgroup of antibody) → IsA → conjugated to enzyme	0.45
antibody → ReceivesAction → used to treat patient	0.45
antibody (aspect of plasma) → ReceivesAction → directed against growth factors	0.45
antibody (aspect of plasma) → ReceivesAction → directed against bifunctional molecules	0.45
antibody → ReceivesAction → tested by elisa	0.45
antibody → ReceivesAction → specified on the datasheet	0.45
antibody → Causes → allergy cells in the body	0.45
antibody → ReceivesAction → used in elisa	0.45
antibody → ReceivesAction → injected	0.45
antibody → CapableOf → protect mouse	0.45
antibody → CapableOf → activate immune system	0.45
antibody → ReceivesAction → directed against growth factors	0.45
specificity (aspect of antibody) → HasProperty → unknown	0.44
secondary antibody (subgroup of antibody) → IsA → aliquoted on arrival	0.44
secondary antibody (subgroup of antibody) → ReceivesAction → stored at -20 °c	0.44
antibody → HasProperty → high	0.44
antibody → CapableOf → develop in the body	0.44
antibody → CapableOf → target ctla-4	0.44
antibody → CapableOf → bind to bacteria	0.44
antibody → ReceivesAction → induced by the vaccine	0.44
antibody → CapableOf → prevent illness	0.44
antibody → CapableOf → bind to toxin	0.44
antibody → ReceivesAction → reduced	0.44
antibody → CapableOf → cross the placenta	0.44
antibody → CapableOf → fight disease	0.44
antibody → CapableOf → activate complement	0.44
antibody → ReceivesAction → directed against cd4	0.44
antibody → CapableOf → block pd-1	0.44
antibody → ReceivesAction → released	0.44
specificity (aspect of antibody) → HasProperty → low	0.44
antibody → CapableOf → float in the bloodstream	0.44
effect (aspect of antibody) → HasProperty → significant	0.44
effect (aspect of antibody) → HasProperty → indirect	0.44
antibody → ReceivesAction → incubated on ice	0.44
antibody → ReceivesAction → cleared	0.44
antibody → ReceivesAction → diluted in 5% dry milk	0.44
antibody → ReceivesAction → donated by different labs	0.44
antibody → MadeOf → same genetic material	0.44
antibody → ReceivesAction → listed in methods	0.44
breast milk (subgroup of milk) → HasA → antibody	0.43
antibody → ReceivesAction → analyzed	0.43
antibody → HasProperty → sensitive	0.43
antibody → CapableOf → attach to virus	0.43
antibody → CapableOf → react with antigen	0.43
antibody → CapableOf → added in single dispensing step	0.43
antibody → IsA → y-shaped protein	0.43
antibody → ReceivesAction → raised against peptide	0.43
antibody → CapableOf → remain attached	0.43
antibody → CapableOf → bind to receptor	0.43
antibody → ReceivesAction → directed against bifunctional molecules	0.43
antibody → ReceivesAction → made to synthetic peptide	0.43
antibody → CapableOf → counteract autoimmune diseases	0.43
antibody → CapableOf → recognize different epitopes	0.42
antibody → CapableOf → attack antigen	0.42
antibody → PartOf → the immune system	0.42
antibody → AtLocation → phase 1 clinical trials	0.42
antibody → ReceivesAction → directed against protein	0.42
antibody → CapableOf → kill the cancer cells	0.42
vaccine → HasA → antibody	0.42
antibody → CapableOf → bind	0.42
antibody → CapableOf → stick to antigen	0.42
antibody → HasProperty → prevalent	0.42
antibody → CapableOf → target pd-l1	0.42
antibody → ReceivesAction → directed against cd11b	0.42
antibody → CapableOf → cure metastatic cancer	0.42
antibody → ReceivesAction → produced by cell	0.42
antibody → CapableOf → react with host tissues	0.42
antibody → IsA → large y-shaped protein	0.42
antibody → ReceivesAction → described	0.42
secondary antibody (subgroup of antibody) → CapableOf → recognize primary antibody	0.42
effect (aspect of antibody) → HasProperty → less pronounced	0.42
effect (aspect of antibody) → HasProperty → consistent	0.42
effect (aspect of antibody) → HasProperty → reversible	0.42
antibody → HasProperty → expensive	0.42
antibody → CapableOf → attack the thyroid	0.42
monoclonal antibody (subgroup of antibody) → ReceivesAction → approved by the fda	0.42
antibody → ReceivesAction → directed against epitope	0.42
antibody → UsedFor → immunoblotting	0.42
antibody → CapableOf → confer immunity	0.42
primary antibody (subgroup of antibody) → ReceivesAction → applied at 4°c	0.42
primary antibody (subgroup of antibody) → ReceivesAction → detected	0.42
antibody → ReceivesAction → used as a loading control	0.41
antibody → CapableOf → block their growth	0.41
secondary antibody (subgroup of antibody) → IsA → mouse igg2b	0.41
antibody → HasA → 1% bovine serum albumin	0.41
antibody → ReceivesAction → produced in the human protein atlas	0.41
antibody → ReceivesAction → created equal	0.41
antibody → HasProperty → dominant	0.41
primary antibody (subgroup of antibody) → ReceivesAction → diluted in 3% bsa	0.41
secondary antibody (subgroup of antibody) → IsA → conjugated to rhodamine	0.41
antibody → CapableOf → use method	0.41
antibody → CapableOf → play subordinate role	0.41
antibody → CapableOf → bind to carbohydrate	0.41
antibody → CapableOf → react with immune effector cells	0.41
effect (aspect of antibody) → HasProperty → important	0.41
effect (aspect of antibody) → HasProperty → modest	0.41
antibody → HasProperty → neutralizing	0.41
antibody → ReceivesAction → secreted	0.41
antibody → CapableOf → neutralize pathogen	0.41
antibody → ReceivesAction → screened	0.41
antibody → CapableOf → recognize	0.41
antibody → CapableOf → remain in circulation	0.41
antibody → ReceivesAction → associated with lupus	0.41
antibody → ReceivesAction → linked to a fluorescent dye	0.40
secondary antibody (subgroup of antibody) → CapableOf → bind to primary antibody	0.40
antibody → ReceivesAction → raised in sheep	0.40
antibody → HasProperty → labile	0.40
antibody → MadeOf → basic structural units	0.40
antibody → CapableOf → attach to substance	0.40
antibody → CapableOf → attach to cancer cells	0.40
antibody → ReceivesAction → associated with protection	0.40
antibody → CapableOf → attack foreign substances	0.40
antibody → ReceivesAction → used as marker	0.40
antibody → CapableOf → target cell	0.40
antibody → HasProperty → preadsorbed using non-phosphopeptide	0.40
antibody → Causes → damage	0.40
effect (aspect of antibody) → HasProperty → rare	0.40
antibody → ReceivesAction → required	0.40
antibody → CapableOf → attach to antigen	0.40
antibody → ReceivesAction → generated by the vaccine	0.40
antibody → ReceivesAction → studied	0.40
antibody → ReceivesAction → induced by immunization	0.40
antibody → ReceivesAction → tested in western blot	0.40
antibody → ReceivesAction → raised against protein	0.40
antibody → CapableOf → travel through the placenta	0.40
antibody → CapableOf → correspond to the site of phosphorylation	0.40
antibody → ReceivesAction → induced by vaccination	0.40
antibody → CapableOf → react with protein	0.40
antibody → CapableOf → block hiv	0.40
antibody → ReceivesAction → used as tool	0.40
primary antibody (subgroup of antibody) → HasProperty → monoclonal	0.40
monoclonal antibody (subgroup of antibody) → ReceivesAction → bound to pcsk9	0.40
monoclonal antibody (subgroup of antibody) → CapableOf → react with antigen	0.40
monoclonal antibody (subgroup of antibody) → ReceivesAction → produced by hybridoma	0.40
monoclonal antibody (subgroup of antibody) → ReceivesAction → given for stage iv gastric cancer	0.40
secondary antibody (subgroup of antibody) → IsA → a goat anti	0.39
antibody → CapableOf → bind to molecule	0.39
antibody → CapableOf → react with the drug-protein conjugate	0.39
antibody → CapableOf → react with visible colored line	0.39
antibody → CapableOf → bind to red blood cells	0.39
antibody → CapableOf → enable immune system	0.39
antibody → ReceivesAction → produced by b lymphocytes	0.39
antibody → ReceivesAction → bound to solid phase	0.39
antibody → HasProperty → absent	0.39
effect (aspect of antibody) → ReceivesAction → observed	0.39
antibody → CapableOf → target antigen	0.39
antibody → ReceivesAction → acquired	0.39
antibody → ReceivesAction → protected	0.39
antibody → CapableOf → kill pathogen	0.39
antibody → CapableOf → enter cell	0.39
antibody → ReceivesAction → used to detect protein	0.39
antibody → UsedFor → ip	0.39
antibody → CapableOf → call antigen	0.39
antibody → CapableOf → attach to protein	0.39
antibody → ReceivesAction → found to thyroglobulin	0.39
antibody → CapableOf → protect animal	0.39
antibody → ReceivesAction → produced against antigen	0.39
antibody → CapableOf → recognize npm	0.39
antibody → CapableOf → prevent the virus	0.39
antibody → ReceivesAction → released into the bloodstream	0.39
specificity (aspect of antibody) → CapableOf → use lysate	0.39
antibody → HasProperty → negative	0.39
secondary antibody (subgroup of antibody) → IsA → goat anti-mouse igg	0.38
secondary antibody (subgroup of antibody) → IsA → conjugated to alexa-488	0.38
antibody → ReceivesAction → elicited	0.38
antibody → CapableOf → attach to the invader	0.38
antibody → Causes → agglutination	0.38
antibody → CapableOf → activate mast cells	0.38
antibody → ReceivesAction → intended for in vitro diagnostic ivduse	0.38
antibody → CapableOf → react with self-antigens autoantigensof the organism	0.38
antibody → CapableOf → invade toxin	0.38
antibody → CapableOf → invade bacteria	0.38
antibody → CapableOf → invade virus	0.38
antibody → CapableOf → target hole	0.38
antibody → ReceivesAction → observed	0.38
effect (aspect of antibody) → ReceivesAction → lost	0.38
antibody → ReceivesAction → linked to radioactive substance	0.38
antibody → ReceivesAction → replenished	0.38
antibody → CapableOf → cut the level of plaques	0.38
primary antibody (subgroup of antibody) → ReceivesAction → incubated at 1:500	0.38
primary antibody (subgroup of antibody) → CapableOf → bind to the target	0.38
primary antibody (subgroup of antibody) → ReceivesAction → used at following dilutions	0.38
effect (aspect of antibody) → ReceivesAction → characterized	0.38
effect (aspect of antibody) → ReceivesAction → mediated	0.38
effect (aspect of antibody) → HasProperty → greater	0.38
antibody → CapableOf → block the interaction	0.38
antibody → CapableOf → trigger immune response	0.38
antibody → CapableOf → bind to first antigen	0.38
antibody → CapableOf → remain elevated	0.38
antibody → CapableOf → recognize pathogen	0.38
antibody → ReceivesAction → immobilized	0.38
antibody → ReceivesAction → labeled with fluorescent dye	0.38
antibody → ReceivesAction → supplied as liquid	0.38
antibody → CapableOf → combine site	0.38
antibody → CapableOf → travel through the bloodstream	0.38
antibody → Causes → hypothyroidism	0.38
antibody → ReceivesAction → labeled with enzyme	0.37
polyclonal antibody (subgroup of antibody) → IsA → protein	0.37
polyclonal antibody (subgroup of antibody) → ReceivesAction → used to neutralize bacteria	0.37
polyclonal antibody (subgroup of antibody) → ReceivesAction → used to neutralize virus	0.37
antibody → CapableOf → work in several ways	0.37
antibody → CapableOf → get into various tissues	0.37
antibody → CapableOf → block ctla-4	0.37
antibody → HasProperty → irrelevant	0.37
antibody → ReceivesAction → tested in mouse	0.37
antibody → CapableOf → circulate in lymph	0.37
antibody → ReceivesAction → bound to the surface	0.37
antibody → CapableOf → do their job	0.37
antibody → CapableOf → slow tumor growth	0.37
antibody → CapableOf → target cancer	0.37
antibody → ReceivesAction → tested to our knowledge	0.37
antibody → CapableOf → attach to foreign substances	0.37
antibody → HasA → two light chains	0.37
antibody → ReceivesAction → indicated on the left	0.37
antibody → HasA → 5% skimmed milk	0.37
antibody → CapableOf → circulate throughout the body	0.37
antibody → CapableOf → target cd4 binding site	0.37
antibody → CapableOf → enter the brain	0.37
antibody → ReceivesAction → validated for western blotting	0.37
antibody → HasProperty → harmless	0.37
antibody → CapableOf → fight toxin	0.37
new drug (subgroup of drug) → IsA → antibody	0.37
antibody → CapableOf → give positive result	0.37
antibody → AtLocation → csf	0.37
antibody → CapableOf → activate platelet	0.37
antibody → CapableOf → trigger inflammatory reaction	0.36
antibody → CapableOf → attack invader	0.36
antibody → CapableOf → vasodilate agent	0.36
antibody → CapableOf → detect cancer	0.36
antibody → CapableOf → interact with cell surface receptors	0.36
antibody → ReceivesAction → produced by the mother	0.36
antibody → CapableOf → bind to foreign antigens	0.36
antibody → CapableOf → confer protection	0.36
antibody → CapableOf → react with antigen determinant sites	0.36
antibody → CapableOf → bind to region	0.36
antibody → ReceivesAction → passed to the baby	0.36
antibody → ReceivesAction → directed against phospholipid	0.36
antibody → HasProperty → low	0.36
antibody → CapableOf → recognize γ-tubulin	0.36
antibody → CapableOf → protect fetus	0.36
antibody → ReceivesAction → directed against egr-1	0.36
effect (aspect of antibody) → CapableOf → occur	0.36
effect (aspect of antibody) → HasProperty → immediate	0.36
antibody → ReceivesAction → used as reagent	0.36
antibody → CapableOf → attack the brain	0.36
therapeutic antibody (subgroup of antibody) → ReceivesAction → used in the clinic	0.36
antibody (aspect of plasma) → HasProperty → specific	0.36
antibody (aspect of plasma) → ReceivesAction → removed with the plasma	0.36
antibody → CapableOf → attack body’s own tissues	0.36
antibody → ReceivesAction → associated with ssc	0.36
antibody → ReceivesAction → involved in rheumatoid arthritis	0.36
antibody → CapableOf → come into contact	0.36
antibody → CapableOf → signal immune system	0.36
antibody → ReceivesAction → developed to treat zika virus infection	0.36
antibody → CapableOf → combine with antigen	0.36
antibody → CapableOf → treat cancer	0.36
antibody → ReceivesAction → secreted by activated plasma cells	0.36
antibody → ReceivesAction → produced by hybridoma	0.36
antibody → CapableOf → fight hiv	0.36
antibody → CapableOf → contribute to immunity	0.36
antibody → CapableOf → label with iodine-125	0.36
antibody → ReceivesAction → directed against actin	0.36
antibody → HasA → effect	0.36
antibody → ReceivesAction → raised against thiolase	0.36
antibody → HasA → two binding sites	0.36
antibody → HasProperty → undetectable	0.36
antibody → CapableOf → appear in response	0.35
antibody → CapableOf → destroy antigen	0.35
primary antibody (subgroup of antibody) → ReceivesAction → conjugated	0.35
antibody → CapableOf → attack tissue	0.35
monoclonal antibody (subgroup of antibody) → ReceivesAction → studied	0.35
monoclonal antibody (subgroup of antibody) → HasProperty → identical	0.35
monoclonal antibody (subgroup of antibody) → IsA → humanized antibody	0.35
monoclonal antibody (subgroup of antibody) → CapableOf → attack the target molecule	0.35
specificity (aspect of antibody) → ReceivesAction → controlled	0.35
antibody → CapableOf → bind to hiv	0.35
antibody → CapableOf → prevent the parasite	0.35
antibody → CapableOf → cross the blood-brain barrier	0.35
antibody → CapableOf → bind tumor	0.35
antibody → CapableOf → attach	0.35
antibody → CapableOf → recognize cd4	0.35
antibody → UsedFor → immunodetection	0.35
antibody → ReceivesAction → raised against such a polypeptide	0.35
antibody → AtLocation → the bloodstream	0.35
antibody → ReceivesAction → produced by patient	0.35
antibody → ReceivesAction → secreted by b cells	0.35
antibody → HasProperty → long-lasting	0.35
antibody → CapableOf → travel to cell	0.35
antibody → HasProperty → immunoreactive	0.35
antibody → CapableOf → monoclonal anti	0.35
antibody → CapableOf → combine antigen determinants	0.35
antibody → ReceivesAction → shown in green	0.35
antibody → ReceivesAction → directed against acetylated tubulin	0.35
effect (aspect of antibody) → ReceivesAction → tested	0.35
effect (aspect of antibody) → ReceivesAction → prevented	0.35
antibody → ReceivesAction → unable to enter the brain	0.35
antibody → CapableOf → persist for life	0.35
antibody → ReceivesAction → bound to bead	0.35
antibody → CapableOf → recognize foreign substances	0.35
antibody → ReceivesAction → used as tracer	0.34
affinity (aspect of antibody) → ReceivesAction → measured	0.34
secondary antibody (subgroup of antibody) → ReceivesAction → diluted in pbs	0.34
secondary antibody (subgroup of antibody) → IsA → alkaline phosphatase	0.34
secondary antibody (subgroup of antibody) → HasProperty → goat anti-rabbit igg h&l	0.34
antibody → CapableOf → recognize single band	0.34
antibody → CapableOf → seek out virus	0.34
antibody → ReceivesAction → referred to neutralizing antibodies	0.34
antibody → MadeOf → protein	0.34
antibody → CapableOf → recognize egfr	0.34
antibody → AtLocation → plasma	0.34
antibody → CapableOf → recognize cd8	0.34
antibody → HasProperty → more common	0.34
antibody → CapableOf → circulate in blood plasma	0.34
antibody → CapableOf → give rise	0.34
antibody → CapableOf → recognize myc	0.34
antibody → CapableOf → call out bigot	0.34
antibody → CapableOf → inhibit parasite growth	0.34
antibody → CapableOf → tag microbe	0.34
antibody → CapableOf → tag infected cell	0.34
antibody → CapableOf → target sialyl lewis a	0.34
antibody → CapableOf → appear in the milk	0.34
antibody → ReceivesAction → used in fig	0.34
antibody → CapableOf → persist for month	0.34
antibody → CapableOf → bind immune antibody-ag complex	0.34
effect (aspect of antibody) → HasProperty → apparent	0.34
antibody → ReceivesAction → combined in therapeutic cocktail.	0.33
antibody → ReceivesAction → added	0.33
specific antibody (subgroup of antibody) → HasProperty → detectable	0.33
antibody → ReceivesAction → expressed	0.33
antibody → CapableOf → work in western blotting	0.33
antibody → CapableOf → form photo-adducts	0.33
antibody → HasA → similar effect	0.33
antibody → ReceivesAction → used at 1:100	0.33
antibody → CapableOf → detect antigen	0.33
antibody → CapableOf → target the acetylcholine receptor	0.33
antibody → ReceivesAction → joined to a t cell	0.33
antibody → CapableOf → reduce non-specific bands	0.33
antibody → CapableOf → target healthy tissue	0.33
antibody → CapableOf → interfere with the conversion of prothrombin	0.33
antibody → ReceivesAction → described in methods	0.33
antibody → ReceivesAction → activated by the occurrence of a disease	0.33
antibody → CapableOf → occur	0.33
antibody → CapableOf → destroy other foreign substances	0.33
antibody → CapableOf → fight off germ	0.33
antibody → ReceivesAction → detected after infection	0.33
antibody → ReceivesAction → tested for reactivity	0.33
antibody → CapableOf → prevent the drug	0.33
antibody → ReceivesAction → produced by immunization of chickens	0.33
antibody → CapableOf → attack the myelin sheath	0.33
antibody → CapableOf → destroy platelet	0.33
antibody → CapableOf → attack healthy tissue	0.33
antibody → CapableOf → recognize exact same	0.33
effect (aspect of antibody) → HasProperty → uncertain	0.33
effect (aspect of antibody) → ReceivesAction → monitored	0.33
effect (aspect of antibody) → HasProperty → direct	0.33
effect (aspect of antibody) → ReceivesAction → shown	0.33
effect (aspect of antibody) → ReceivesAction → limited	0.33
antibody → CapableOf → attack kidney	0.33
primary antibody (subgroup of antibody) → ReceivesAction → diluted in 5% milk	0.33
monoclonal antibody (subgroup of antibody) → ReceivesAction → purified	0.33
monoclonal antibody (subgroup of antibody) → CapableOf → block ctla-4	0.33
antibody → AtLocation → saliva	0.32
effect (aspect of antibody) → HasProperty → stronger	0.32
antibody → CapableOf → destroy red blood cells	0.32
antibody → CapableOf → attack allergen	0.32
antibody → ReceivesAction → likely to be effective	0.32
antibody → ReceivesAction → composed of two heavy chains	0.32
antibody → HasA → unique variable region	0.32
antibody → CapableOf → identify toxic beta-amyloid plaques	0.32
antibody → HasProperty → central	0.32
antibody → AtLocation → colostrum	0.32
antibody → IsA → a blood protein	0.32
antibody → CapableOf → match antigen	0.32
antibody → CapableOf → recognize peptide	0.32
antibody → CapableOf → react with their respective targets	0.32
antibody → ReceivesAction → directed against the flag-tag	0.32
antibody → HasProperty → small	0.32
antibody → CapableOf → recognize p53	0.32
antibody → ReceivesAction → induced	0.32
antibody → ReceivesAction → internalized	0.32
antibody → CapableOf → call out the fear-mongers	0.32
antibody → HasProperty → normal	0.32
antibody → CapableOf → incubate for 1 h	0.32
antibody → CapableOf → patrol the body	0.32
antibody → ReceivesAction → produced against bacteria	0.32
antibody → CapableOf → bind to gp120	0.32
antibody → CapableOf → recognize molecule	0.32
antibody → ReceivesAction → produced by blood cells	0.32
antibody → CapableOf → bind to the drug	0.32
antibody → ReceivesAction → immobilized in filter	0.32
antibody → CapableOf → bind to only one specific antigen	0.32
antibody → ReceivesAction → used to treat rheumatoid arthritis	0.32
antibody → CapableOf → suppress immune system	0.32
antibody → ReceivesAction → directed against nestin	0.32
antibody → ReceivesAction → produced in individual	0.32
antibody → CapableOf → recognise homogalacturonan domain of pectic polysaccharides	0.32
antibody → CapableOf → react with bovine	0.32
antibody → CapableOf → bind to dna	0.32
antibody → CapableOf → become primed	0.32
antibody → CapableOf → protect against zika infection	0.32
antibody → ReceivesAction → present in the sample	0.32
antibody → ReceivesAction → raised against isocitrate lyase	0.32
antibody → ReceivesAction → detected by solid-phase immunoassay	0.32
antibody → ReceivesAction → directed against the ha epitope	0.32
antibody → HasProperty → more effective	0.32
antibody → HasSubevent → their destruction	0.32
effect (aspect of antibody) → HasProperty → serious	0.32
polyclonal antibody (subgroup of antibody) → ReceivesAction → produced by conventional techniques	0.32
antibody → ReceivesAction → reported	0.32
antibody → HasProperty → harmful	0.32
antibody → CapableOf → cause autoimmune disease	0.32
antibody → CapableOf → neutralize antigen	0.32
antibody → HasProperty → weak	0.32
antibody → Causes → encephalitis	0.32
antibody → CapableOf → destroy their targets	0.32
antibody → CapableOf → destroy cell	0.31
antibody → CapableOf → destroy baby’s red blood cells	0.31
antibody → CapableOf → attack lung	0.31
neutralizing antibody (subgroup of antibody) → CapableOf → confer protection	0.31
neutralizing antibody (subgroup of antibody) → ReceivesAction → directed against the hiv-1 envelope glycoprotein	0.31
effect (aspect of antibody) → HasSubevent → perinuclear distribution of rac2	0.31
effect (aspect of antibody) → HasProperty → cumulative	0.31
effect (aspect of antibody) → HasProperty → additive	0.31
effect (aspect of antibody) → HasProperty → short-lived	0.31
effect (aspect of antibody) → ReceivesAction → shown in fig	0.31
effect (aspect of antibody) → ReceivesAction → reversed	0.31
effect (aspect of antibody) → ReceivesAction → abolished by ex-9	0.31
effect (aspect of antibody) → HasProperty → severe	0.31
antibody → CapableOf → stick to the virus	0.31
antibody → ReceivesAction → tested for cross	0.31
antibody → CapableOf → comprise binding domains	0.31
antibody → CapableOf → referred to herein	0.31
antibody → ReceivesAction → associated with the disease	0.31
antibody → ReceivesAction → injected into the brain	0.31
antibody → CapableOf → protect against certain strains of influenza virus	0.31
antibody → CapableOf → inhibit invasion	0.31
antibody → CapableOf → neutralize viral infection	0.31
antibody → CapableOf → inactivate the antigen	0.31
antibody → CapableOf → combine with foreign substances	0.31
antibody → ReceivesAction → attached to nanoparticle	0.31
antibody → ReceivesAction → released in the body	0.31
antibody → ReceivesAction → labelled with fluorophore	0.31
antibody → ReceivesAction → directed against human vegfr2	0.31
antibody → ReceivesAction → secreted in primary response	0.31
antibody → HasProperty → recombinant	0.31
antibody → CapableOf → bind to the nicotine	0.31
antibody → CapableOf → target regulatory t cells	0.31
antibody → CapableOf → recognize invader	0.31
antibody → ReceivesAction → directed against insulin	0.31
antibody → CapableOf → mimic the ligand	0.31
antibody → CapableOf → bind to microbe	0.31
antibody → ReceivesAction → used as primary antibodies	0.31
antibody → CapableOf → help to protect pidd patients	0.31
antibody → CapableOf → prolong survival	0.31
antibody → CapableOf → bind components of the complement system	0.31
antibody → HasA → long half-lives	0.31
antibody → ReceivesAction → excluded	0.31
antibody → CapableOf → inhibit erythrocyte invasion	0.31
antibody → ReceivesAction → mixed	0.31
antibody → ReceivesAction → removed by chromatography	0.31
antibody → HasProperty → ubiquitous	0.31
antibody → CapableOf → differentiate	0.31
antibody → CapableOf → trigger reaction	0.31
antibody → ReceivesAction → delivered	0.31
antibody → CapableOf → use protein	0.31
antibody → CapableOf → pave the way	0.31
antibody → ReceivesAction → shown to be specific	0.31
antibody → ReceivesAction → released into the circulation	0.31
antibody → ReceivesAction → directed against icam-1	0.31
antibody → AtLocation → buffer	0.31
antibody → CapableOf → target igf-1r	0.31
antibody → CapableOf → bind to each other	0.31
antibody → CapableOf → bind to c3	0.31
antibody → CapableOf → bind to c5	0.31
antibody → CapableOf → bind to factor d	0.31
antibody → CapableOf → recognize marker	0.31
antibody → CapableOf → recognize hpv-16l1	0.31
antibody → CapableOf → bind to pcsk9	0.31
antibody → CapableOf → recognize certain kind of nanoparticle	0.31
antibody → ReceivesAction → tagged with a his-tag	0.31
antibody → ReceivesAction → tested in wb	0.31
antibody → CapableOf → keep virus	0.31
antibody → CapableOf → target given site	0.31
antibody → ReceivesAction → elicited in different species	0.31
antibody → ReceivesAction → directed against wide variety of interspecies-specific antigens	0.31
antibody → CapableOf → coat internal linings of the body	0.31
antibody → CapableOf → target cytokine	0.31
antibody → CapableOf → protect macaque	0.31
antibody → IsA → globular proteins	0.31
antibody → ReceivesAction → used to protect other first responders	0.31
antibody → CapableOf → target an igg control	0.31
antibody → CapableOf → recognize phosphorylated akt expression	0.31
antibody → CapableOf → recognize cd14	0.31
antibody → ReceivesAction → curated by the beta cell biology consortium	0.31
antibody → CapableOf → target tumour markers	0.31
antibody → ReceivesAction → directed against usf1	0.31
specificity (aspect of antibody) → ReceivesAction → increased	0.31
specificity (aspect of antibody) → ReceivesAction → characterized in one set of experiments	0.31
secondary antibody (subgroup of antibody) → IsA → a hrp polymer	0.31
antibody → CapableOf → destroy the thyroid gland	0.31
antibody → CapableOf → attack body’s own cells	0.31
antibody → CapableOf → attack cell	0.31
antibody → ReceivesAction → added to the control	0.30
mucus → HasA → antibody	0.30
antibody → CapableOf → release histamine	0.30
antibody → Causes → allergic reaction	0.30
antibody → HasProperty → efficient	0.30
antibody → CapableOf → attack the body	0.30
antibody → CapableOf → shown efficacy	0.30
primary antibody (subgroup of antibody) → ReceivesAction → listed in table	0.29
primary antibody (subgroup of antibody) → ReceivesAction → listed in additional file	0.29
primary antibody (subgroup of antibody) → ReceivesAction → replaced by igg	0.29
monoclonal antibody (subgroup of antibody) → ReceivesAction → paired with radioactive material	0.29
monoclonal antibody (subgroup of antibody) → CapableOf → carry drug	0.29
monoclonal antibody (subgroup of antibody) → CapableOf → recognize antigen	0.29
monoclonal antibody (subgroup of antibody) → ReceivesAction → directed against the pbcsp repeat region	0.29
antibody → Causes → basophil	0.29
antibody → CapableOf → come to intracellular proteins	0.29
antibody → ReceivesAction → optimized	0.29
antibody → CapableOf → give similar results	0.29
antibody → CreatedBy → leaky gut phenomenon	0.29
antibody → CapableOf → bind to viral proteins	0.29
antibody → HasProperty → chimeric	0.29
antibody → ReceivesAction → scored	0.29
antibody → CapableOf → react at low temperatures	0.29
antibody → CapableOf → recognize flag	0.29
antibody → ReceivesAction → described in patient	0.29
antibody → CapableOf → recognize gfp	0.29
antibody → ReceivesAction → blocked by acquired human antibodies	0.29
antibody → ReceivesAction → tested in ip	0.29
antibody → CapableOf → reconstitute lyophilized antibodies	0.29
antibody → ReceivesAction → diluted in facs buffer	0.29
antibody → CapableOf → prolong partial thromboplastin time	0.29
antibody → ReceivesAction → stored at -20°c	0.29
antibody → ReceivesAction → described in supplementary materials	0.29
antibody → CapableOf → bind to il-12	0.29
antibody → ReceivesAction → covered by our guarantee	0.29
antibody → ReceivesAction → raised against immunogen	0.29
antibody → CapableOf → protect cell	0.29
antibody → CapableOf → mediate protection	0.29
antibody → ReceivesAction → replaced	0.29
antibody → ReceivesAction → directed	0.29
antibody → ReceivesAction → tagged with a myc-tag eqkliseedl	0.29
antibody → CapableOf → shown potent cancer cell killing capacity	0.29
antibody → CapableOf → belong to subclass	0.29
antibody → CapableOf → block acetylcholine	0.29
antibody → CapableOf → recognize retinal proteins	0.29
antibody → ReceivesAction → used in conjunction	0.29
antibody → ReceivesAction → directed against myc	0.29
antibody → CapableOf → attack optic nerves	0.29
antibody → CapableOf → attack spinal cord	0.29
polyclonal antibody (subgroup of antibody) → ReceivesAction → expensive to produce	0.29
effect (aspect of antibody) → CapableOf → feel unwell	0.29
antibody → CapableOf → attack healthy cells	0.29
antibody → CapableOf → attack skin	0.29
antibody → CapableOf → attack joint	0.29
antibody → HasProperty → difficult	0.28
antibody → CapableOf → attack protein	0.28
effect (aspect of antibody) → ReceivesAction → observed in neutrophil	0.28
effect (aspect of antibody) → HasProperty → complex	0.28
effect (aspect of antibody) → ReceivesAction → estimated	0.28
effect (aspect of antibody) → HasProperty → absent	0.28
effect (aspect of antibody) → ReceivesAction → studied at day	0.28
effect (aspect of antibody) → HasProperty → reproducible	0.28
effect (aspect of antibody) → ReceivesAction → abolished	0.28
effect (aspect of antibody) → HasProperty → inconsistent	0.28
effect (aspect of antibody) → ReceivesAction → pronounced	0.28
effect (aspect of antibody) → ReceivesAction → blocked	0.28
effect (aspect of antibody) → ReceivesAction → caused	0.28
effect (aspect of antibody) → HasProperty → large	0.28
effect (aspect of antibody) → HasProperty → negligible	0.28
antibody → HasProperty → autoreactive	0.28
antibody → CapableOf → latch on to a neighboring sugar	0.28
monoclonal antibody (subgroup of antibody) → ReceivesAction → used as primary antibodies	0.28
antibody → ReceivesAction → raised	0.28
antibody → CapableOf → cure the tumor	0.28
antibody → ReceivesAction → transferred	0.27
antibody → ReceivesAction → introduced	0.27
antibody → HasProperty → crossreactive	0.27
antibody → HasProperty → unknown	0.27
antibody → HasProperty → rendered photoactive	0.27
antibody → CapableOf → failed to complex with any of the target cells	0.27
antibody → ReceivesAction → detected in cerebrospinal fluid	0.27
antibody → CapableOf → send signal	0.27
antibody → HasProperty → broad	0.27
antibody → ReceivesAction → calibrated against a spectrum of antigens	0.27
antibody → CapableOf → react with single band	0.27
antibody → ReceivesAction → shipped at ambient temperature	0.27
antibody → Causes → rhesus disease	0.27
antibody → CapableOf → stick to lymphoma cells	0.27
antibody → CapableOf → incubate at 37°c	0.27
antibody → ReceivesAction → directed against sequence	0.27
antibody → CapableOf → consist of 0.5	0.27
antibody → ReceivesAction → detected by enzyme-linked immunosorbent assay	0.27
antibody → ReceivesAction → combined with chemotherapy	0.27
antibody → CapableOf → surround antigen	0.27
antibody → CapableOf → recognize β-actin	0.27
antibody → ReceivesAction → validated in chip	0.27
antibody → ReceivesAction → developed to chinese-hamster-ovary cell proteins	0.27
antibody → CapableOf → recognize hiv	0.27
antibody → ReceivesAction → attached to infected cells	0.27
antibody → CapableOf → recognize amino acids	0.27
antibody → ReceivesAction → cited	0.27
antibody → CapableOf → attach to infectious bronchitis virus	0.27
antibody → CapableOf → recognize tag	0.27
antibody → ReceivesAction → grown	0.27
antibody → ReceivesAction → directed against r&d systems	0.27
antibody → ReceivesAction → directed against vimentin	0.27
antibody → CapableOf → differentiate self	0.27
antibody → ReceivesAction → fused	0.27
antibody → CapableOf → react against their own leukemia cells	0.27
antibody → ReceivesAction → elevated in all 20 patients	0.27
antibody → CapableOf → wash with pbs	0.27
antibody → CapableOf → bind with the phage	0.27
antibody → CapableOf → bind to neutrokine-α	0.27
antibody → CapableOf → recognize neu5gc	0.27
antibody → HasProperty → short-lived	0.27
antibody → CapableOf → block lag3	0.27
antibody → CapableOf → recognize active caspase	0.27
antibody → CapableOf → recognize rpl5	0.27
antibody → CapableOf → compete with each other	0.27
antibody → ReceivesAction → precipitated	0.27
antibody → CapableOf → block hap2	0.27
antibody → CapableOf → recognize hole	0.27
antibody → ReceivesAction → produced in natural human infection	0.27
antibody → CapableOf → recruit other cells	0.27
antibody → ReceivesAction → directed against eftu	0.27
antibody → CapableOf → act in cooperation	0.27
antibody → CapableOf → employ purified phospholipid	0.27
antibody → CapableOf → alert immune system	0.27
antibody → ReceivesAction → bound to solid support	0.27
antibody → CapableOf → seek cell-surface proteins	0.27
antibody → CapableOf → recognise germ	0.27
antibody → CapableOf → recognize siglec-14	0.27
antibody → CapableOf → promote phagocytosis	0.27
antibody → CapableOf → react with fak	0.27
antibody → IsA → naturally-derived biological molecules	0.27
antibody → ReceivesAction → raised against total egfr	0.27
antibody → ReceivesAction → raised against purified lipolytic enzyme	0.27
antibody → CapableOf → recognize centrosome-associated γ-tubulin protein	0.27
antibody → ReceivesAction → raised by two months time	0.27
antibody → CapableOf → recognize fabp5	0.27
antibody → CapableOf → attack heart	0.27
antibody → Causes → swelling	0.27
monoclonal antibody (subgroup of antibody) → CapableOf → provide protection	0.27
effect (aspect of antibody) → CapableOf → wear off over time	0.27
antibody → ReceivesAction → infected	0.26
antibody → Causes → hemolysis	0.26
effect (aspect of antibody) → ReceivesAction → reported	0.26
antibody → ReceivesAction → detected in sera	0.26
antibody → CapableOf → destroy healthy tissue	0.25
antibody → CapableOf → react with the food	0.25
antibody → CapableOf → block the receptor	0.25
antibody → ReceivesAction → damaged	0.25
antibody → HasProperty → less effective	0.25
antibody → CapableOf → recognize extracellular epitope	0.25
antibody → CapableOf → unlock antitumor t-cell activity	0.25
antibody → CapableOf → recognize mineralocorticoid receptor	0.25
antibody → ReceivesAction → produced in the cns	0.25
antibody → HasA → special section	0.25
antibody → CapableOf → neutralize harmful protein particles	0.25
antibody → CapableOf → inhibit second viral protein	0.25
antibody → CapableOf → recognize the viral surface protein hemagglutinin	0.25
antibody → CapableOf → inhibit viral neuraminidase	0.25
antibody → ReceivesAction → directed against mouse	0.25
antibody → CapableOf → increase in number	0.25
antibody → CapableOf → inhibit plasmodium falciparum adhesion	0.25
antibody → CapableOf → block function	0.25
antibody → ReceivesAction → directed against wnv	0.25
antibody → ReceivesAction → directed against tbev	0.25
antibody → CapableOf → occur in gastric and mucus secretions	0.25
antibody → CapableOf → tag pathogen	0.25
antibody → CapableOf → exhibit different affinities	0.25
antibody → ReceivesAction → fixed	0.25
antibody → CapableOf → target exact types of influenza virus	0.25
antibody → CapableOf → lock onto antigen	0.25
antibody → ReceivesAction → mapped	0.25
antibody → CapableOf → fight off flu	0.25
antibody → ReceivesAction → bound to magnetic particles	0.25
antibody → ReceivesAction → inexpensive to produce	0.25
antibody → CapableOf → interact in complex biochemical process	0.25
antibody → UsedFor → chip-seq	0.25
antibody → ReceivesAction → directed against dsdna	0.25
antibody → CapableOf → target ror1	0.25
antibody → Causes → aggregation or agglutination of particulate	0.25
antibody → CapableOf → preincubate with the control peptide antigen	0.25
antibody → ReceivesAction → produced without infection	0.25
antibody → ReceivesAction → retained in endoplasmic reticulum	0.25
antibody → CapableOf → affect the baby	0.25
antibody → ReceivesAction → unable to complex	0.25
antibody → CapableOf → decrease aortic valve calcification	0.25
antibody → CapableOf → decrease hepatic steatosis	0.25
antibody → CapableOf → react with endothelial cells	0.25
antibody → CapableOf → test positive	0.25
antibody → CapableOf → target abeta	0.25
antibody → HasA → same specificity	0.25
antibody → CapableOf → recognize intruder	0.25
antibody → CapableOf → neutralize the dengue virus	0.25
antibody → ReceivesAction → directed against extracellular domain	0.25
antibody → AtLocation → camel	0.25
antibody → ReceivesAction → purified by ammonium sulfate precipitation	0.25
antibody → ReceivesAction → directed against hla-a2	0.25
antibody → ReceivesAction → used to immunoprecipitate chromatin	0.25
antibody → CapableOf → neutralize heterologous wild-type mumps virus	0.25
antibody → CapableOf → bind to the peptide	0.25
antibody → ReceivesAction → recommended by the manufacturer	0.25
antibody → CapableOf → acetylate histone h3	0.25
antibody → HasProperty → bispecific	0.25
antibody → ReceivesAction → stored in 50% glycerol	0.25
antibody → CapableOf → target immune checkpoints	0.25
antibody → CapableOf → react with the ebola virus surface glycoprotein	0.25
antibody → CapableOf → bind to fibronectin	0.25
antibody → CapableOf → recognize ebola	0.25
antibody → CapableOf → recognize dengue fever	0.25
antibody → CapableOf → recognize yellow fever	0.25
antibody → ReceivesAction → detected in first six months	0.25
antibody → ReceivesAction → derived by placental transfer	0.25
antibody → ReceivesAction → followed by ib	0.25
antibody → CapableOf → react with immunoglobulin	0.25
antibody → ReceivesAction → applied at 4°c	0.25
antibody → CapableOf → protect neuron	0.25
antibody → ReceivesAction → secreted into intestinal lumen	0.25
antibody → CapableOf → form lattice	0.25
antibody → CapableOf → recognize histone h3	0.25
antibody → CapableOf → detect in untested species	0.25
antibody → CapableOf → target tim-3	0.25
antibody → ReceivesAction → directed against neuronal antigens	0.25
antibody → CapableOf → bind to three-dimensional structure	0.25
antibody → CapableOf → form the basis of a vaccine	0.25
antibody → ReceivesAction → directed against synaptophysin	0.25
antibody → ReceivesAction → induced by experimental malaria vaccines	0.25
antibody → CapableOf → signal of il-4	0.25
antibody → CapableOf → signal of il-13	0.25
antibody → CapableOf → target nerve growth factor	0.25
antibody → CapableOf → bind body's own epitopes	0.25
antibody → CapableOf → occur in two physical forms	0.25
antibody → ReceivesAction → grouped into five isotypes	0.25
antibody → CapableOf → target the delivery of chemotherapy	0.25
antibody → ReceivesAction → directed against sec61β	0.25
antibody → CapableOf → display immunoreactivity	0.25
antibody → CapableOf → trigger the destruction of their tumors	0.25
antibody → HasProperty → defensive	0.25
antibody → CapableOf → refer to single chain	0.25
antibody → CapableOf → refer to humanized	0.25
antibody → CapableOf → replace both sox2	0.25
antibody → CapableOf → replace c-myc	0.25
antibody → CapableOf → recognize critical brain protein	0.25
antibody → CapableOf → directed against self	0.25
antibody → CapableOf → react with the selfantigens	0.25
antibody → CapableOf → bind to gp41	0.25
antibody → ReceivesAction → used to distinguish adenocarcinoma	0.25
antibody → ReceivesAction → ordered	0.25
antibody → CapableOf → provide complete protection	0.25
antibody → ReceivesAction → detected in piglet	0.25
antibody → CapableOf → provide the calf's immunity	0.25
antibody → CapableOf → prevent plaque deposition	0.25
antibody → CapableOf → target α-synuclein	0.25
antibody → ReceivesAction → directed against red	0.25
antibody → CapableOf → use rabbit igg	0.25
antibody → CapableOf → attach to foreign particle	0.25
antibody → CapableOf → make body chemicals	0.25
antibody → CapableOf → treat the skin disease psoriasis	0.25
antibody → CapableOf → treat inflammatory bowel disease	0.25
antibody → CapableOf → block the s100-tlr4 axis	0.25
antibody → CapableOf → block active heterodimers	0.25
antibody → ReceivesAction → attached to gold nanoparticles	0.25
antibody → CapableOf → recognize second infection	0.25
antibody → CapableOf → recognize different dengue serotypes	0.25
antibody → ReceivesAction → directed against 1:200	0.25
antibody → AtLocation → child	0.25
antibody → CapableOf → wane over time	0.25
antibody → ReceivesAction → produced by the capsule	0.25
antibody → CapableOf → recognize fak	0.25
antibody → CapableOf → define sites of vulnerability	0.25
antibody → CapableOf → stain against egfp	0.25
antibody → CapableOf → bind to either c4	0.25
antibody → CapableOf → prevent cleavage	0.25
antibody → CapableOf → bind to c1q	0.25
antibody → ReceivesAction → indicated at left side of the panels	0.25
antibody → CapableOf → recognize single polypeptide	0.25
antibody → ReceivesAction → followed by dialysis	0.25
antibody → CapableOf → block merozoite invasion	0.25
antibody → ReceivesAction → used to protect pregnant women	0.25
antibody → ReceivesAction → raised against recombinant protein	0.25
antibody → ReceivesAction → developed by bio-rad	0.25
antibody → CapableOf → raise against anapn1	0.25
antibody → ReceivesAction → manufactured on site	0.25
antibody → ReceivesAction → evaluated on denatured microarray	0.25
antibody → CapableOf → recognize phospho serine	0.25
antibody → CapableOf → occur with an organ transplant	0.25
antibody → CapableOf → target gitr	0.25
antibody → CapableOf → dilute 1:50	0.25
antibody → Causes → demyelination	0.25
antibody → ReceivesAction → approved for immunohistochemistry analysis	0.25